Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: A stabilisation of an epidemic of viral induced carcinoma?

European Journal of Cancer

Volumn 51, Issue 1, 2015, Pages 55-61

  Näsman, Anders ^a   Nordfors, Cecilia ^a   Holzhauser, Stefan ^a   Vlastos, Andrea ^a,b   Tertipis, Nikolaos ^a   Hammar, Ulf ^b   Hammarstedt Nordenvall, Lalle ^a,b   Marklund, Linda ^a,b   Munck Wikland, Eva ^a,b   Ramqvist, Torbjörn ^a   Bottai, Matteo ^b   Dalianis, Tina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

HPV; HPV and base of tongue cancer; HPV and oropharyngeal cancer; HPV and tonsillar cancer; HPV induced epidemic of tonsillar and base of tongue cancer a follow up

Indexed keywords

PROTEIN P16; VIRUS DNA;

ADULT; AGE; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CLINICAL EVALUATION; CONTROLLED STUDY; EPIDEMIC; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ORAL BIOPSY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SWEDEN; TONGUE CARCINOMA; TONSIL CARCINOMA; TUMOR BIOPSY; VIRUS CARCINOGENESIS; WART VIRUS; GENETICS; INCIDENCE; OROPHARYNGEAL NEOPLASMS; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; RISK FACTOR; TONGUE NEOPLASMS; TONSILLAR NEOPLASMS; VIROLOGY;

FEMALE; HUMANS; INCIDENCE; MALE; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; TONGUE NEOPLASMS; TONSILLAR NEOPLASMS;

EID: 84925436503     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.10.016     Document Type: Article

References (39)

1. WHO. IARC monographs on the evaluation of carcinogenic risk to humans. Lyon, France: International Agency for Research on Cancer; 2007.
2. M.L. Gillison, W.M. Koch, R.B. Capone, M. Spafford, W.H. Westra, and L. Wu Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
3. H. Mellin, S. Friesland, R. Lewensohn, T. Dalianis, and E. Munck-Wikland Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival Int J Cancer 89 2000 300 304
4. L. Dahlgren, H.M. Dahlstrand, D. Lindquist, A. Högmo, L. Björnestål, and J. Lindholm Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients Int J Cancer 112 2004 1015 1019
5. L. Marklund, A. Näsman, T. Ramqvist, T. Dalianis, E. Munck-Wikland, and L. Hammarstedt Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer Cancer Med 1 2012 82 88
6. D. Lindquist, M. Romanitan, L. Hammarstedt, A. Nasman, H. Dahlstrand, and J. Lindholm Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7 Mol Oncol 1 2007 350 355
7. P. Attner, J. Du, A. Nasman, L. Hammarstedt, T. Ramqvist, and J. Lindholm Human papillomavirus and survival in patients with base of tongue cancer Int J Cancer 128 2011 2892 2897
8. T. Ramqvist, and T. Dalianis Oropharyngeal cancer epidemic and human papillomavirus Emerg Infect Dis 16 2010 1671 1677
9. T. Dalianis Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review) Int J Oncol 44 2014 1799 1805
10. L. Hammarstedt, D. Lindquist, H. Dahlstrand, M. Corneliu, L. Dahlgren, and J. Joneberg Human papillomavirus infection may account for the increase in tonsillar cancer Int J Cancer 119 2006 2620 2623
11. A. Nasman, P. Attner, L. Hammarstedt, J. Du, M. Eriksson, and G. Giraud Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125 2009 362 366
12. P. Attner, J. Du, A. Nasman, L. Hammarstedt, T. Ramqvist, and J. Lindholm The role of human papillomavirus in the increased incidence of base of tongue cancer Int J Cancer 126 2010 2879 2884
13. L. Hammarstedt, H. Dahlstrand, D. Lindquist, L. Onelov, M. Ryott, and J. Luo The incidence of tonsillar cancer in Sweden is increasing Acta Otolaryngol 127 2007 988 992
14. J.S. Hocking, A. Stein, E.L. Conway, D. Regan, A. Grulich, and M. Law Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers Br J Cancer 104 2011 886 891
15. V.M. Reddy, D. Cundall-Curry, and M.W. Bridger Trends in the incidence rates of tonsil and base of tongue cancer in England, 1985-2006 Ann R Coll Surg England 92 2010 655 659
16. M. Blomberg, A. Nielsen, C. Munk, and S.K. Kjaer Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites Int J Cancer 129 2011 733 741
17. A.K. Chaturvedi, E.A. Engels, W.F. Anderson, and M.L. Gillison Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States J Clin Oncol 26 2008 612 619
18. J.A. Ernster, C.G. Sciotto, M.M. O'Brien, J.L. Finch, L.J. Robinson, and T. Willson Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus Laryngoscope 117 2007 2115 2128
19. A.K. Chaturvedi, W.F. Anderson, J. Lortet-Tieulent, M.P. Curado, J. Ferlay, and S. Franceschi Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers J Clin Oncol 31 2013 4550 4559
20. M.C. Romanitan, A. Näsman, T. Ramqvist, H. Dahlstrand, L. Polykretis, and P. Vogiatzis Human papillomavirus frequency in oral and oropharyngeal cancer in Greece Anticancer Res 28 2008 2077 2080
21. K.B. Pytynia, K.R. Dahlström, and E.M. Sturgis Epidemiology of HPV-associated oropharyngeal cancer Oral Oncol 50 2014 380 386
22. G. D'Souza, Y. Agrawal, J. Halpern, S. Bodison, and M.L. Gillison Oral sexual behaviors associated with prevalent oral human papillomavirus infection J Inf Dis 199 2009 1263 1269
23. A.R. Kreimer, R.K. Bhatia, A.L. Messeguer, P. Gonzalez, R. Herrero, and A.R. Giuliano Oral human papillomavirus in healthy individuals: a systematic review of the literature Sex Transm Dis 37 2010 386 391
24. C.H. Chung, A. Bagheri, and G. D'Souza Epidemiology of oral human papillomavirus infection Oral Oncol 50 2014 364 369
25. S. Syrjänen, and M. Puranen Human papillomavirus infections in children: the potential role of maternal transmission Crit Rev Oral Biol Med 11 2000 259 274
26. A. Leval, E. Herweijer, L. Arnheim-Dahlström, H. Walum, E. Frans, and P. Sparén Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability J Infect Dis 206 2012 860 866
27. R. Herrero, W. Quint, A. Hildesheim, P. Gonzalez, L. Struijk, and H.A. Katki Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica PLoS One 8 2013 e68329
28. M. Schmitt, B. Dondog, T. Waterboer, and M. Pawlita Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers J Clin Microbiol 46 2008 1050 1059
29. A. Nasman, E. Andersson, L. Marklund, N. Tertipis, L. Hammarstedt-Nordenvall, and P. Attner HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome PLoS One 8 2013 e77025
30. D. Lindquist, A. Ahrlund-Richter, M. Tarján, T. Tot, and T. Dalianis Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer Anticancer Res 32 28 2012 153 161
31. C. Nordfors, A. Vlastos, J. Du, A. Ährlund-Richter, N. Tertipis, and N. Grün Human papillomavirus prevalence is high in oral samples of patients with tonsillar and base of tongue cancer Oral Oncol 50 2014 491 497
32. L. Sivars, A. Näsman, N. Tertipis, A. Vlastos, T. Ramqvist, and T. Dalianis Human papillomavirus (HPV) and p53 expression in metastasis from unknown primary head and neck cancer in relation to clinical outcome Cancer Med 3 2014 376 384
33. H. Mellin Dahlstrand, D. Lindquist, L. Bjornestal, A. Ohlsson, T. Dalianis, and E. Munck-Wikland P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma Anticancer Res 25 2005 4375 4383
34. M. Hoffmann, S. Tribius, E.S. Quabius, H. Henry, S. Pfannenschmidt, and C. Burkhardt HPV DNA, E6∗I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker? Cancer Lett 323 2012 88 96
35. S.J. Smeets, A.T. Hesselink, E.J. Speel, A. Haesevoets, P.J. Snijders, and M. Pawlita A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen Int J Cancer 121 2007 2465 2472
36. D. Holzinger, M. Schmitt, G. Dyckhoff, A. Benner, M. Pawlita, and F.X. Bosch Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement Cancer Res 72 2012 4993 5003
37. S. Syrjanen HPV infections and tonsillar carcinoma J Clin Pathol 57 2004 449 455
38. A. Nasman, E. Andersson, C. Nordfors, N. Grun, H. Johansson, and E. Munck-Wikland MHC class I expression in HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical outcome Int J Cancer 132 2013 72 81
39. A.M. Hong, A.E. Grulich, D. Jones, C.S. Lee, S.M. Garland, and T.A. Dobbins Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets Vaccine 28 2010 3269 3272